TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC)

Intrinsic and/or acquired resistance to cisplatin is a significant obstacle in the treatment of muscle-invasive bladder cancer. p73, a p53 homolog and determinant of chemosensitivity, is rarely mutated in bladder cancer (BC). However p73 expression and therefore function can be repressed through epi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell Cycle
Egile Nagusiak: Bunch, Brittany, Krishnan, Nithya, Greenspan, Rebecca D., Ramakrishnan, Swathi, Attwood, Kristopher, Yan, Li, Qi, Qianya, Wang, Dan, Morrison, Carl, Omilian, Angela, Bshara, Wiam, Pili, Roberto, Trump, Donald L., Johnson, Candace, Woloszynska, Anna
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2019
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6681839/
https://ncbi.nlm.nih.gov/pubmed/31318640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2019.1638693
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak